Becton, Dickinson and Company (BKK:BDX06)

Market Cap	1.84T -22.4%
Revenue (ttm)	709.23B +8.2%
Net Income	54.49B -1.6%
EPS	189.00 -0.7%
Shares Out	n/a
PE Ratio	33.74
Forward PE	n/a
Dividend	0.03 (1.29%)
Ex-Dividend Date	Dec 8, 2025

Volume	n/a
Average Volume	36,815
Open	2.120
Previous Close	2.180
Day's Range	2.120 - 2.120
52-Week Range	1.750 - 2.220
Beta	n/a
RSI	56.00
Earnings Date	Feb 9, 2026

About BKK:BDX06

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BDX06

Financial Performance

In fiscal year 2025, BKK:BDX06's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD